Sydney biotech firm develops highly-effective COVID vaccine

Reported on Wednesday the 13th of October 2021 on msm

A Sydney based firm develops highly effective COVID vaccine very different to those curranty on offer.

MSM puppet host explains Engeneic uses Nanocellular technology to stimulate a strong antibody response. Not only has it been found to work against mutant strains including Delta, its also shown promising signs of efficacy and doesn’t require refrigeration. A trial is currently underway at Melbourne’s St Vincennes Hospital.

Engeneic Co-CEO Dr Jennifer MacDiarmid goes on to explain “We have developed a Nanocell where we load up the COVID spike protean so it comes pre-packaged. The other vaccines you have to make the spike protean when its injected in the body from any cell it goes into.

Its presented as a dry powder, you just add water. There’s no keeping it at -80c like the other vaccines and it has a shelf life of around 3 to 4 years (Not tested as yet) where the others run out of OMF in about 3 months.

Currently testing this with Cancer patients and the results have been promising with the immediate rise within 3 hours of the white blood cells (immune cells)